Abstract:Background and objective: Chronic insomnia has major consequences for daytime functioning, yet no fully validated patient-reported outcome instrument for once-daily assessments is available to measure these consequences. This study describes the development and psychometric evaluation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ). Methods: The Daytime Insomnia Symptom Scale (DISS), an existing 20-item instrument for assessing daytime functioning, was modified to give an 18-item version of the IDSIQ (IDSIQ-18) based on iterative qualitative interviews with 54 subjects with insomnia and expert input. The construct validity and other psychometric properties of the IDSIQ-18 were analyzed based on an interventional study (NCT03056053) in which subjects with insomnia received zolpidem (5 or 10 mg) daily for 2 weeks and an observational study among subjects with no diagnosis of insomnia (good sleepers). Participants in both studies completed the IDSIQ-18 daily for 2 weeks. Exit interviews were conducted with a sample of subjects who completed the interventional study to elicit concepts defining the experience of insomnia, to assess understanding of the response scales, and to determine meaningful change thresholds. Exploratory factor analysis and Rasch analysis were conducted to further assess the structure and latent model for the scoring of the final IDSIQ instrument. Further psychometric evaluation of the final IDSIQ was then conducted. Results: Subjects in both the interventional study (N = 114) and observational study (N = 103) were predominantly female (65% for subjects with insomnia and 60% for good sleepers). Mean age was 51 years for subjects with insomnia and 45 years for good sleepers. Subjects in the exit interviews (N = 41) demonstrated a good understanding of the IDSIQ-18 response scales. Day 1 mean scores were higher (worse) in subjects with insomnia compared with good sleepers. Based on inter-item correlation, exploratory factor, and Rasch analyses and review of the qualitative data, four items were removed. This yielded the final IDSIQ, with 14 items comprising three domains: Alert/Cognition, Mood, and Sleepiness. The domain structure was determined in a confirmatory factor analysis. Evidence of internal consistency reliability was strong: day 1 Cronbach's alpha was 0.917 for IDSIQ total score and 0.806-0.918 for the domains. Test-retest reliability, assessed for subjects with insomnia with no change on the Patient Global Assessment of Disease Severity scale between day 1 and day 8, was also good (intra-class correlation coefficient 0.856-0.911). Meaningful change thresholds derived for this sample using anchor-based approaches were 20 for IDSIQ total score, 9 for the Alert/Cognition domain, 4 for the Mood domain, and 4 for the Sleepiness domain. Conclusions: These studies, which closely followed Food and Drug Administration Guidance for Industry on patient-reported outcome measures, support use of the IDSIQ as a fit-for-purpose measure for deriving valid and reliable endpoints in insomnia clinical research trials and real-world studies.

Data-driven shortened Insomnia Severity Index (ISI): a machine learning approach

Psychometric Properties of the Insomnia Severity Index and Its Comparison With the Shortened Versions Among the General Population

The simplification of the insomnia severity index and epworth sleepiness scale using machine learning models

Evaluation of a Brief Three-Item Insomnia Severity Index (ISI-3) Among Healthcare Workers

Psychometric Evaluation of the Insomnia Severity Index in U.S. College Students

Fine tuned personalized machine learning models to detect insomnia risk based on data from a smart bed platform

Psychometric Evaluation of the Insomnia Severity Index in Nurses

Dysfunctional Beliefs and Attitudes about Sleep-6 (DBAS-6): Data-driven Shortened Version from a Machine Learning Approach

Identifying the best sleep measure to screen clinical insomnia in a psychiatric population

A concise, machine learning-based questionnaire that screens for insomnia and apnoea in the general population

Abbreviated versions of the Insomnia Severity Index to screen for comorbid insomnia among obstructive sleep apnea patients

Psychometric properties of the Insomnia Severity Index (ISI) in Mexican adults

Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ)

Evaluation of Severity Levels of the Athens Insomnia Scale Based on the Criterion of Insomnia Severity Index

Psychometric Properties of the Insomnia Severity Index Among Arabic Chronic Diseases Patients

Factor Analysis of the Insomnia Severity Index and Epworth Sleepiness Scale in Shift Workers

Validation of the Athens Insomnia Scale for screening insomnia in South Korean firefighters and rescue workers

Psychometric and structural properties of the traditional Chinese version of the sleep condition indicator for patients undergoing hemodialysis

Latent profile of the insomnia severity index: A longitudinal study

A longitudinal examination of the measurement properties and invariance of the Sleep Condition Indicator in Chinese healthcare students

Psychometric properties of Indonesian version of sleep condition indicator for screening poststroke insomnia